tiprankstipranks
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Canadian Market
BLAB
Britannia Life Sciences Inc
RESEARCH TOOLSreports

Britannia Life Sciences Inc (BLAB) Income Statement

2 Followers

Britannia Life Sciences Inc Income Statement

Last quarter (Q4 2024), Britannia Life Sciences Inc's total revenue was C$-5.09M, a decrease of -3098.46% from the same quarter last year. In Q4, Britannia Life Sciences Inc's net income was C$9.46M. See Britannia Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Jun 23Jun 22Mar 22Mar 21
Total Revenue
C$ 369.28KC$ 7.57MC$ 6.40MC$ 7.30MC$ 1.42M
Gross Profit
C$ 27.33KC$ 4.85MC$ 4.64MC$ 5.26MC$ 1.17M
Operating Expenses
C$ 2.28MC$ 4.68MC$ 4.46MC$ 4.88MC$ 1.06M
Depreciation and Amortization
C$ 60.17KC$ 328.38KC$ 226.67KC$ 189.54KC$ 69.57K
EBITDA
C$ -4.39MC$ -1.90MC$ 6.95MC$ -10.77MC$ -1.62M
Operating Income
C$ -2.25MC$ 173.00KC$ 177.74KC$ 379.57KC$ 114.83K
Other Income/Expenses
C$ -2.31MC$ -4.64MC$ 5.68MC$ -13.65MC$ 285.81K
Pretax Income
C$ -4.56MC$ -4.47MC$ 5.86MC$ -13.27MC$ 400.64K
Net Income
C$ 7.39MC$ -4.77MC$ 5.08MC$ -15.46MC$ -157.16K
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.03C$ 0.03C$ -0.14C$ 0.00
Diluted EPS
C$ -0.03C$ -0.03C$ 0.03C$ -0.14C$ 0.00
Weighted Average Shares Outstanding
 162.25M 162.25M 162.14M 109.50M 76.75M
Weighted Average Shares Outstanding (Diluted)
 162.25M 162.25M 162.14M 109.50M 77.63M
Currency in CAD

Britannia Life Sciences Inc Earnings and Revenue History